Vitalhub Corp. (TSE:VHI) Receives Consensus Recommendation of “Buy” from Analysts

by · The Markets Daily

Vitalhub Corp. (TSE:VHI – Get Free Report) has been given a consensus rating of “Buy” by the seven research firms that are covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is C$13.00.

Several analysts have recently commented on the stock. National Bank Financial reduced their price target on shares of Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 27th. Canaccord Genuity Group set a C$15.00 price objective on Vitalhub and gave the stock a “buy” rating in a research report on Friday, August 28th.

View Our Latest Report on Vitalhub

Vitalhub Stock Performance

Vitalhub stock opened at C$8.04 on Tuesday. The company has a 50-day moving average price of C$7.50 and a 200 day moving average price of C$7.52. Vitalhub has a 12-month low of C$6.46 and a 12-month high of C$11.91. The stock has a market cap of C$508.61 million, a P/E ratio of 67.00, a PEG ratio of 1.18 and a beta of 1.14.

Vitalhub (TSE:VHI – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported C$0.03 earnings per share for the quarter. Vitalhub had a net margin of 5.89% and a return on equity of 2.79%. The company had revenue of C$31.74 million for the quarter. As a group, analysts forecast that Vitalhub will post 0.2296467 EPS for the current year.

About Vitalhub

(Get Free Report)

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.

Further Reading